StockNews.com began coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the technology company’s stock.
Separately, HC Wainwright cut their price objective on Applied DNA Sciences from $7.00 to $1.50 and set a buy rating on the stock in a research note on Monday, June 10th.
Get Our Latest Stock Report on APDN
Applied DNA Sciences Trading Up 33.4 %
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last posted its quarterly earnings results on Friday, May 10th. The technology company reported ($5.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($4.60) by ($0.71). Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. The firm had revenue of $0.93 million for the quarter, compared to analysts’ expectations of $0.90 million. Research analysts anticipate that Applied DNA Sciences will post -2.95 EPS for the current year.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new stake in Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned about 0.72% of Applied DNA Sciences as of its most recent SEC filing. 22.22% of the stock is currently owned by institutional investors.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Read More
- Five stocks we like better than Applied DNA Sciences
- Golden Cross Stocks: Pattern, Examples and Charts
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Using the MarketBeat Dividend Tax Calculator
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Invest in Insurance Companies: A GuideĀ
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.